Maintaining a consistent sleep-wake schedule, including exposure to bright light in the morning and avoidance of it at night, may be the most reliable way to reduce pandemic-induced sleep problems.
For patients with SCD, anxiety significantly mediates the effect of sleep disturbances on executive functioning more than depression.
Greater risk for relapse was observed in patients with lower self-efficacy for sleep and more dysfunctional beliefs about sleep.
In patients who have experienced an ischemic stroke, obstructive sleep apnea severity has been positively associated with 3-month poststroke depression.
Sleep-onset problems in the first year of life may precede an autism spectrum disorder diagnosis in children at higher risk for ASD.
Sleep duration shorter or longer than 7 hours may be associated with increased cardiovascular health risks.
Researchers evaluated the relationship between patient-reported fatigue and serum biomarkers in axial spondyloarthritis.
Poor sleep quality is associated with increased food intake and a lower-quality diet among women.
While carefully timed light exposure may address sleep problems associated with circadian rhythm disturbances, studies that examine light therapies in the context of sleep disorders have been largely lacking in measures of adherence and acceptability of these approaches.
Positive topline data from the phase 3 REST-ON trial evaluating FT218 (Avadel), an investigational, once-nightly formulation of sodium oxybate, showed that the treatment led to clinically meaningful improvement in patients with narcolepsy.